R1 RCM runs outsourced revenue cycle operations for healthcare providers, integrating with Epic, Cerner and Meditech on a .NET and Azure core. Adoption of Databricks, Python and Terraform alongside OpenAI points to a data and AI push, matching projects on agent-based RCM systems and a centralized warehouse. Hiring is accelerating and skews junior and healthcare-operations heavy, concentrated in the Philippines and India.
Notable leadership hires: Workplace Services Director, Ops Lead
R1 RCM is a public company headquartered in Chicago, IL, founded in 2003, that provides technology-enabled revenue cycle management to healthcare providers and health systems. Its offering combines automation, AI and human operations across registration, coding, billing and payer interactions, plus physician advisory, practice management and emergency medical services work. The company employs more than 10,000 people, with delivery teams spanning the United States, India and the Philippines. Its platform connects to major EHR systems including Epic, Cerner and Meditech.
R1 RCM builds on C#, .NET, ASP.NET Core, React and Angular, with SQL Server, Snowflake, Databricks and Azure Data Factory for data, Azure DevOps for delivery, and integrates with Epic, Cerner and Meditech.
R1 RCM hires in the Philippines, India and the United States, with hiring accelerating and weighted toward junior healthcare operations and support roles.
Yes. R1 RCM uses OpenAI and is adopting Databricks and Python, with active projects on AI-driven agent-based revenue cycle systems and autonomous healthcare workflow automation.
Other companies in the same industry, closest in size
R1 RCM's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.